DID YOU KNOW…The number of trials registered at clinicaltrials.gov has nearly tripled from 2000 to 2014.
Along with an escalating number of trials, drug and medical device developers face increasingly complex trial protocols, fierce competition for patients in certain therapeutic areas, an expanded global trial landscape, and increased regulatory requirements. As a result, the cost and time needed to secure clinical trial sites has soared.
Take a look at our detailed infographic, filled with eye-opening statistics, to learn more about challenges with clinical trial site selection and potential solutions to lower the cost and time needed to secure well-qualified sites:
Sponsors and CROs are competing for high-performing sites in the most common disease areas of clinical research. Currently, according to The Center for Information and Study on Clinical Research Participation, the highest number of trials are for oncology and immunomodulators, central nervous system, anti-infectives, cardiovascular, and diabetes treatments. Therefore, it’s important to find sites with a demonstrated track record of good performance in trials similar to your study and site personnel with strong credentials to increase the probability of effective recruitment and a successful trial.
Another challenge of site selection is identifying the site’s correct qualifications. However, many new technology tools are now available for sites to disclose their qualifications and credentials to sponsors and CROs. It’s necessary to evaluate both a site’s productivity in past clinical trials and real-time feasibility for a new trial.
Taking time to ensure that selected sites have the appropriate qualifications, staff motivation, patient population, infrastructure, and support at the outset will help secure consistent, high-quality enrollment during the course of your trial.